Also trades as: NVO (NYSE) · $vol 469M · NOVO-B.CO (CPH) · $vol 179M · NOV.DE (XETRA) · $vol 8M · NOVC.DE (XETRA) · $vol 5M · NOVO.TO (TSX) · $vol 0M

$37.01

-0.37 (-0.99%)

Weekly Expected Move ±4.1%

$34 $36 $37 $39 $40

OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 43 · $164.3B mcap · 3.15B float · 0.0023% daily turnover · Short 13% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$308.4B +6.2% ▲

5Y CAGR: +19.4%

Gross Profit

$247.7B +0.8% ▲

5Y CAGR: +18.5%

Operating Income

$134.7B +5.0% ▲

5Y CAGR: +20.0%

Net Income

$102.2B +1.2% ▲

5Y CAGR: +19.4%

EPS (Diluted)

$22.98 +1.5% ▲

5Y CAGR: +20.6%

EBITDA

$149.1B +8.5% ▲

5Y CAGR: +20.2%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$140.8B	$177.0B	$232.3B	$290.4B	$308.4B
YoY Growth	+10.9%	+25.7%	+31.3%	+25.0%	+6.2%
Cost of Revenue	$23.7B	$28.4B	$35.8B	$44.5B	$60.6B
Gross Profit	$117.1B	$148.5B	$196.5B	$245.9B	$247.7B
Gross Margin	83.2%	83.9%	84.6%	84.7%	80.3%
R&D Expenses	$17.8B	$24.0B	$32.4B	$48.1B	$45.1B
SG&A Expenses	$41.1B	$50.7B	$61.6B	$67.4B	$70.3B
Operating Expenses	$58.5B	$73.7B	$93.9B	$117.5B	$113.0B
Operating Income	$58.6B	$74.8B	$102.6B	$128.3B	$134.7B
Operating Margin	41.7%	42.3%	44.2%	44.2%	43.7%
Interest Expense	$289M	$378M	$739M	$1.6B	$4.2B
Income Before Tax	$59.1B	$69.3B	$104.7B	$127.2B	$130.2B
Tax Expense	$11.3B	$13.5B	$21.0B	$26.2B	$28.0B
Net Income	$47.8B	$55.5B	$83.7B	$101.0B	$102.2B
Net Margin	33.9%	31.4%	36.0%	34.8%	33.1%
EPS (Diluted)	$10.37	$12.22	$9.31	$22.64	$22.98
EBITDA	$64.8B	$76.8B	$111.0B	$137.4B	$149.1B
Shares Outstanding	4.61B	4.54B	4.49B	4.46B	4.45B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$71.3B	$85.7B	$78.1B	$76.9B	$75.0B	$79.0B	$96.8B	$78.5B
Cost of Revenue	$11.3B	$13.0B	$12.9B	$12.8B	$17.9B	$15.1B	$13.6B	$17.1B
Gross Profit	$60.0B	$72.7B	$65.2B	$64.0B	$57.1B	$64.0B	$83.2B	$61.4B
Gross Margin	84.1%	84.8%	83.5%	83.3%	76.1%	81.0%	86.0%	78.2%
R&D Expenses	$9.5B	$13.8B	$10.3B	$11.7B	$15.4B	$14.6B	$10.3B	$17.8B
SG&A Expenses	$16.6B	$20.3B	$16.1B	$18.8B	$17.3B	$17.4B	$13.2B	$16.3B
Operating Expenses	$26.2B	$35.9B	$26.4B	$30.6B	$33.4B	$32.3B	$23.6B	$34.3B
Operating Income	$33.8B	$36.7B	$38.8B	$33.4B	$23.7B	$31.7B	$59.6B	$27.1B
Operating Margin	47.4%	42.9%	49.7%	43.5%	31.6%	40.2%	61.6%	34.5%
Interest Expense	$821M	-$2.8B	$5.2B	$5.0B	$5.0B	-$10.9B	$3.5B	$1.5B
Income Before Tax	$34.4B	$35.6B	$37.0B	$33.8B	$25.5B	$34.2B	$62.2B	$26.9B
Tax Expense	$7.1B	$7.3B	$8.0B	$7.3B	$5.5B	$7.3B	$13.6B	$5.9B
Net Income	$27.3B	$28.2B	$29.0B	$26.5B	$20.0B	$26.8B	$48.6B	$21.0B
Net Margin	38.3%	32.9%	37.2%	34.5%	26.7%	34.0%	50.2%	26.7%
EPS (Diluted)	$6.12	$6.33	$6.53	$5.96	$4.50	$6.03	$10.91	$4.74
EBITDA	$37.4B	$40.1B	$46.0B	$43.6B	$33.8B	$37.3B	$69.2B	$38.7B
Shares Outstanding	4.46B	4.46B	4.45B	4.45B	4.45B	4.45B	4.45B	4.44B

NONOF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet